Lundbeck announces availability of ONFI Tablets in the U.S.

By News Medical — From Published at January 4, 2012 Views 1,543

Lundbeck announced today that ONFI Tablets are now available for prescribing in the United States. The FDA recently approved ONFI for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients two years and older. ONFI is an oral anti-epileptic drug (AED) of the benzodiazepine class, and is a 1,5 benzodiazepine. ONFI (pronounced "ON-fē") is a federally controlled schedule four substance (C-IV).

"The availability of ONFI is the result of extensive efforts over many years by our team here at Lundbeck and the medical community," said Staffan Schüberg, president of Lundbeck in the U.S. "We have been inspired by the courage of patients and families impacted by LGS, and their strength never to give up on the goal of additional seizure management. Recognizing the need for additional treatment options due to the intractable nature of this challenging seizure disorder, we are very pleased to make ONFI available in the U.S."

Read the full article at Bullet-go

  • Report Report as inappropriate
  • Share
    Email Email
    Print Print Twitter Twitter
    Facebook Facebook

Comments (No comments)

Add your comment Reply Down